Human_peripheral_blood_lymphocytes_targeted_with_bispecific_antibodies_release_cytokines_that_are_essential_for_inhibiting_tumor_growth._We_have_compared_the_mechanisms_by_which_human_PBL_targeted_with_bispecific_antibodies_either_lyse_tumor_cells_or_block_their_growth_in_culture_or_in_mice._We_found_that_resting_PBL_were_unable_to_mediate_lysis,_but_were_able_to_block_tumor_growth._Moreover,_targeted_PBL_were_unable_to_lyse_bystander_cells,_whereas_targeted_PBL_did_block_the_growth_of_bystander_tumor_cells_in_culture_and_in_nude_mice._Supernatants_from_cultures_of_targeted_PBL,_or_from_PBL_grown_on_anti-CD3-coated_flasks,_blocked_the_growth_of_tumor_cells_in_the_absence_of_added_effector_cells,_and_antibodies_against_TNF-alpha_and_IFN-gamma_reversed_the_inhibition_of_tumor_growth,_but_had_no_effect_upon_cytolysis_mediated_by_targeted_by_PBL._Our_results_show_that_targeted_human_PBL_mediate_two_different_antitumor_activities:_lysis,_which_occurs_rapidly_and_requires_the_direct_attachment_of_the_target_cell_to_the_cytotoxic_cell,_and_tumor_growth_inhibition,_which_is_mediated_by_cytokines_released_into_the_medium_as_a_result_of_receptor_cross-linking._The_inhibition_of_bystander_tumor_growth_in_mice_by_targeted_PBL_suggests_that_factor_release_is_sufficient_to_block_tumor_growth_in_vivo._Targeted_factor_release_therefore_provides_a_mechanism_by_which_targeted_PBL_could_block_the_growth_of_tumor_cells_in_vivo_that_were_not_bound_by_the_effector_cells,_but_which_were_located_in_the_vicinity_of_tumor_cells_that_were_bound.